Global Brain Health Supplements Market 2016-2024: Focus on Memory Enhancement, Mood and Depression, Attention and Focus, Longevity and Anti-aging, Sleep, Recovery and Dream Enhancement and Anxiety - Research and Markets
Opioid Makers Sued for Stoking Addiction -- WSJ
Ohio Sues Five Drug Firms, Saying They Fueled Opioid Crisis -- Update
Ohio Sues Five Drug Firms, Saying They Fueled Opioid Crisis -- 2nd Update
CARMA Therapeutics Closes Initial Funding to Advance Chimeric Antigen Receptor Macrophages (CARMA) to Treat Solid Tumors
Cephalon CEPH announced Monday that Gabitril did not meet the primary endpoints in a Phase III study for generalized anxiety disorder (GAD). We're sticking with our fair value estimate of $44 per share, as we had assumed only a modest increase in Gabitril sales from this additional indication. ...
The proposed Salix acquisition boosts our fair value estimate significantly.
While we remain bullish on the sector, health-care growth depends on the economy.
This article represents opinions of the author and not those of his firm and are subject to change from time to time and do not constitute a recommendation to purchase and sale any security nor to engage in any particular investment strategy. The information contained here has been obtained from ...